Groups | CON (vehicle) | 25 M (25 × 106 pCPC) | 50 M (50 × 106 pCPC) | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Day 7 (healthy) | Day 0 (preinjection) | 1 week | 10 weeks | Day 7 (healthy) | Day 0 (preinjection) | 1 week | 10 weeks | Day 7 (healthy) | Day 0 (preinjection) | 1 week | 10 weeks | |
LVEF (%) | 54.9 ± 11.2 | 38.0 ± 9.6 | 40.4 ± 5.4 | 42.1 ± 10.0 | 52.5 ± 6.4 | 41.7 ± 8.1 | 42.8 ± 7.6 | 46.5 ± 7.4 | 52.0 ± 6.2 | 40.1 ± 6.5 | 43.7 ± 6.5 | 50.2 ± 4.9* |
EDVi (mL/m2) | 80.0 ± 18.4 | 105.0 ± 10.6 | 111.7 ± 11.2 | 119.0 ± 24.8 | 80.1 ± 11.7 | 97.2 ± 9.7 | 108.6 ± 15.3 | 104.3 ± 14.2 | 84.1 ± 10.1 | 94.8 ± 14.7 | 97.5 ± 17.6 | 94.0 ± 11.4** |
ESVi (mL/m2) | 36.5 ± 12.7 | 65.4 ± 14.5 | 66.7 ± 10.5 | 70.5 ± 25.5 | 38.3 ± 8.5 | 56.7 ± 9.2 | 62.8 ± 15.3 | 56.3 ± 14.0 | 40.4 ± 7.3 | 56.7 ± 11.9 | 56.2 ± 17.8 | 47.0 ± 8.2** |
Infarct (%) | n/a | 16.7 ± 5.1 | 11.3 ± 2.7 | 8.3 ± 2.8* | n/a | 14.6 ± 6.1 | 11.0 ± 6.7 | 8.7 ± 5.2 | n/a | 13.4 ± 5.3 | 11.0 ± 5.4 | 5.9 ± 4.1* |
edema (%) | n/a | 23.4 ± 5.9 | 18.7 ± 4.4 | 6.7 ± 1.1 | n/a | 25.2 ± 6.6 | 14.2 ± 5.4 | 6.7 ± 3.9 | n/a | 27.3 ± 8.4 | 15.0 ± 4.2 | 5.3 ± 3.6 |